|
|
Current Issue:
March 2022 | Vol 59 | Issue 5 |
|
| Original Article |
|
| Safety of osimertinib in adult patients with metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: Results from a Phase IV study in India |
|
 |
|
| Prabhat S Malik, Vanita Noronha, Deepak Dabkara, Vamshi K Maddu, Senthil Rajappa, Sewanti Limaye, Ullas Batra |
|
|
Background: A Phase IV, single-arm study was conducted to assess the safety of osimertinib in Indian patients with epidermal growth factor receptor (EGFR) T790M mutation-positive stage... |
|
| [Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub] |
| |
| Original Article |
|
| CONCORDANCE: A real-world evidence study to evaluate the concordance of detecting epidermal growth factor receptor (EGFR) mutation by circulating tumor DNA* versus tissue biopsy in patients with metastatic non-small cell lung cancer |
|
 |
|
| Kumar Prabhash, Bivas Biswas, Sachin Khurana, Ullas Batra, Ghanashyam Biswas, Suresh Hariram Advani, Prabrajya N Mohapatra, Senthil Rajappa, Ajay Sharma, Shekhar Patil, Palanki Satya Dattatreya, Rakesh Roy, Sachin Almel, Gautam Goyal, Narayanankutty Warrier |
|
|
Background: Molecular tissue testing in non-small cell lung cancer (NSCLC) is done for the assessment of epidermal growth factor receptor (EGFR) mutation. EGFR mutation status is the basis fo... |
|
| [Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub] |
Read more.... |
|
|
 |
|
Indian Journal of Cancer (ISSN 0019-509X), the show window of the
progress of oncological sciences in India, was established in 1963.
Indian Journal of Cancer is the first and only periodical serving the
needs of all the specialties of oncology in India. Its international
repute is recognized by its indexing with most bibliographic databases
including MEDLINE, Index Medicus, EMBASE and Biological Abstracts.
The readership has expanded beyond the boundaries of thecountry.
Apart from journal's |
own website, the internet issue of the journal has
been made available with collaboration with Bioline International,
Canada. The journal's content from www.bioline.org.br/cn attracts more
than 5000 visitors per month, from all over the world. The journal
utilizes most advanced tools for its management including an electronic
system for manuscript submission and review.
More >>
|
|
